Thursday, January 1, 2026
Today's Print

Tag: Bharat Biotech

Russia: WHO yet to approve Sputnik over lack of data

Russia on Tuesday admitted that its homegrown Sputnik V coronavirus vaccine had not yet been approved by the World Health Organization because Russian authorities...

WHO looking forward to oral, nasal Covid vaccines

The World Health Organization's chief scientist said Tuesday she was looking forward to the "second generation" of Covid-19 vaccines, which could include nasal sprays...

FDA approves use of Bharat anti-virus vax

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 11.0px; font: 12.0px 'Myriad Pro'} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; text-indent: 9.0px; line-height:...

India vaccines

Entrepreneurial advocacy group Go Negosyo holds a briefing with a number of private companies on COVID-19 vaccine Covaxin, manufactured by India’s Bharat Biotech. Around...

India reviews AstraZeneca side effects over blood clot fears

India will carry out a deeper review of post-vaccination side effects from the AstraZeneca shot next week although no cases of blood clots have...

Bharat Biotech’s Covaxin Phase 3 interim efficacy at 81%

The Phase 3 clinical trial results of Bharat Biotech's coronavirus vaccine candidate, Covaxin, yielded an 81 percent interim efficacy in India. "Covaxin demonstrated 81 percent...

Indian PM receives Bharat Biotech vaccine

Indian Prime Minister Narendra Modi was recently administered a Covaxin shot, developed by Bharat Biotech, at New Delhi's AIIMS hospital, making him the first...

India authorizes two vaccines for emergency use

India has authorized the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University and by local pharmaceutical firm Bharat Biotech, the...
- Advertisement -spot_img
- Advertisement -spot_img